Please confirm you are human

This browser or connection looks automated. Press and continuously hold the control for 3 seconds to enable Google-hosted web results and, when separately allowed, AI-assisted answers.

A successful check enables 100 search requests. Interactive access does not authorize scraping, systematic collection, or reuse of search output.

Hold with a pointer, or hold Space or Enter.

News

FirstWord Pharma
firstwordpharma.com > story > 7984983

WCLC26: GSK's ris-rez cuts death risk 54% in China Phase III lung cancer trial

5+ hour, 55+ min ago   (16+ words) FirstWord Pharma...

Pulse 2.0
pulse2.com > lilly-completes-acquisition-of-ataibeckley-to-expand-mental-health-pipeline

Lilly Completes Acquisition Of AtaiBeckley To Expand Mental Health Pipeline

1+ day, 9+ hour ago   (600+ words) The transaction was completed after AtaiBeckley shareholders approved the acquisition at a special meeting, clearing the way for the company to become part of Lilly’s broader research and development organization. Lilly plans to use the transaction to broaden its neuroscience…...

TechStock²
ts2.tech > en > exelixis-fda-delay-moves-zanzalintinib-decision-to-march-2027

Exelixis FDA Delay Moves Zanzalintinib Decision to March 2027

1+ day, 10+ hour ago   (10+ words) TechStock²...

Los Angeles Times
latimes.com > california > story > 2026-09-11 > cyclosporiasis-outbreak-that-sickened-thousands-is-officially-over

Cyclosporiasis outbreak that sickened tens of thousands officially over, CDC says

1+ day, 20+ hour ago   (549+ words) The massive diarrhea-causing parasitic outbreak that sickened tens of thousands of people across 21 states over the summer has ended, though officials continue to investigate the cause of contamination. On Friday, the U.S. Centers for Disease Control and Prevention declared the cyclosporiasis…...

STAT
statnews.com > 09/11/2026 > scholar-rock-spinal-muscular-atrophy-isembyld-clinical-trial-fda-approval

Scholar Rock wins FDA approval for first drug to target SMA muscle loss

1+ day, 21+ hour ago   (214+ words) STAT is a media company focused on finding and telling compelling stories about health, medicine, and scientific discovery. We produce daily news, investigative articles, and narrative projects in addition to multimedia features, podcasts, and opinion pieces. We tell our stories…...

STAT
statnews.com > pharmalot > 09/11/2026 > pharma-wins-cost-of-wastewater-treatment-fight-europe

Pharma wins a battle over the cost of wastewater treatment in Europe

1+ day, 22+ hour ago   (180+ words) In a boost for the pharmaceutical industry, a European Union Advocate General recommended annulling part of a directive that requires drug and cosmetics manufacturers to finance at least 80% of the costs of wastewater treatment. The directive, which revised an earlier…...

@959thesportsnut
freedom959.net > 09/11/2026 > us-fda-approves-scholar-rocks-muscle-weakness-drug

US FDA approves Scholar Rock’s muscle weakness drug

1+ day, 23+ hour ago   (80+ words) Sept 11 (Reuters) - ​The ‌U.S. Food and ‌Drug ​Administration ⁠on ⁠Friday approved Scholar ​Rock's ⁠therapy ⁠to ​treat ​a rare genetic ‌condition ⁠that causes muscle ⁠weakness. (Reporting ‌by ⁠Sneha ​S ‌K in ​Bengaluru; ⁠Editing by Tasim ​Zahid)... US FDA approves Scholar…...

US News & World Report
usnews.com > news > world > articles > 2026-09-11 > us-declares-end-of-largest-recorded-cyclosporiasis-outbreak

US Declares End of Largest Recorded Cyclosporiasis Outbreak

2+ day, 6+ hour ago   (34+ words) US News is a recognized leader in college, grad school, hospital, mutual fund, and car rankings. Track elected officials, research health conditions, and find news you can use in politics, business, health, and education....

Stevens Point
wsau.com > 09/11/2026 > astrazenecas-breast-cancer-drug-fails-late-stage-trial

Astrazeneca’s breast cancer drug fails late-stage trial

1+ day, 23+ hour ago   (77+ words) Sept 11 (Reuters) - ​AstraZeneca ‌said on Friday ‌its ​breast ⁠cancer ⁠drug failed ​to ⁠meet ⁠the main ​goal ​of improving ‌progression-free survival ⁠during a late-stage ⁠trial. (Reporting ‌by ⁠Christy ​Santhosh ‌in ​Bengaluru; ⁠Editing by Tasim ​Zah... Astrazeneca’s breast cancer drug fails late-stage…...

wncy.com
wncy.com > 09/10/2026 > us-fda-pauses-new-enrollment-in-biohavens-epilepsy-drug-trials

US FDA pauses new enrollment in Biohaven’s epilepsy drug trials

3+ day, 3+ hour ago   (293+ words) Sept 10 (Reuters) – Biohaven said on Thursday the U.S. FDA had imposed a partial clinical hold, pausing new patient enrollment in trials of its experimental epilepsy drug ​after rodent findings, sending its shares down more than ‌15% in early trading. • The U....